DUBLIN–(BUSINESS WIRE)–The “Spatial OMICS Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Spatial OMICS Market is projected to reach USD 845.58 million by 2027 from USD 414.49 million in 2021, at a CAGR 12.61% during the forecast period. In this report, the years 2019 and 2020 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Medical Aesthetic Devices Market Size By Type, By Application, By End-use, and By Region Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The global medical aesthetic devices market size is expected to reach USD 34.54 Billion in 2030 and register a revenue CAGR of 11.08% over the forecast period, according to … [Read more…]
Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from 2L and 3L ER+/HER2- advanced or metastatic breast cancer Submission supported by results from the pivotal Phase 3 EMERALD study of elacestrant showing statistically significant efficacy over current standard-of-care (SOC) medications for both the overall … [Read more…]
New deal strengthens Congenica’s presence in India CAMBRIDGE, England–(BUSINESS WIRE)–#lifechanginganswers–Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, today announces a partnership with Avesthagen, a biotechnology major that specialises in predictive, preventive and personalised healthcare through the convergence of food, pharma and population genetics. Congenica’s … [Read more…]
MELBOURNE, Australia–(BUSINESS WIRE)–LifeWorks, a market-leading provider of comprehensive mental health, digital and in-person total wellbeing solutions, today announced an agreement with Cover-More Group to acquire Benestar, a leading employee assistance program (EAP) and workplace wellbeing provider in Australia and New Zealand. Benestar is wholly owned by Cover-More, a company of Zurich Insurance Group. The acquisition … [Read more…]
Conference Call and Webcast August 11 at 8:00 am Eastern Time / 7:00 am Central Time Company Confident in Plan to Resolve Issues that Led to Clinical Hold of Phase 2/3 ReMEDy2 Trial Proposal to Resume Trial Will be Submitted to FDA in September Cash Runway Into 2024 MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a … [Read more…]
Michael Smith to retire after 5 years of service; Jeff Schwaneke named to agilon board AUSTIN, Texas–(BUSINESS WIRE)–agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Michael Smith will retire from agilon health’s board of directors after more than five years of service. Upon … [Read more…]
– Completed positive End-of-Phase 2 meeting with the Food and Drug Administration (“FDA”) and received scientific advice from the European Medicines Agency (“EMA”) to support design of its CALM Phase 3 program, which is expected to initiate in Q4 2022 – – Ended second quarter 2022 with approximately US$384.6 million in pro-forma cash, cash equivalents … [Read more…]
– Efficacy Observed with QINLOCK® was Comparable to Sunitinib with a More Favorable Safety and Tolerability Profile in GIST Patients Previously Treated with Imatinib – WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that … [Read more…]
WASHINGTON–(BUSINESS WIRE)–The Partnership for Safe Medicines, a public health group committed to the safety of pharmaceutical medicines, applauds the International Criminal Police Organization (INTERPOL) for organizing the seizure of over $11 million in counterfeit medicines during Operation Pangea XV, an initiative to combat the global trafficking of counterfeit pharmaceuticals marketed and sold online. During the … [Read more…]
